Determination of Risk Factors of Shoulder Pathologies in Parkinson Disease

NCT ID: NCT06456840

Last Updated: 2024-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-15

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Parkinson's disease was first described in history in 1817 by James Parkinson in his monograph "An essay on swinging palsy", and today it is the 2nd most common neurodegenerative disease after Alzheimer's, affecting approximately 6.1 million people. Its main histopathological feature is the decrease in dopaminergic secretion in the basal ganglia and there are three cardinal findings: Bradykinesia, Tremor, Rigidity. Although joint and skeletal deformities are seen in approximately 70% of Parkinson's patients, they are not adequately evaluated and cause significant functional disability and chronic pain, independent of motor symptoms.Musculoskeletal pathologies seen in Parkinson's patients can be classified as: musculoskeletal pain, articular problems, postural problems and bone mineralization defects. The shoulder girdle is a joint with complex and delicate function, consisting of four joints (glenohumeral, sternoclavicular, acromioclavicular and scapulothoracic), supporting muscles and periarticular ligaments, which seriously affects the patient's quality of daily life and function. Although magnetic resonance imaging (MRI) is the best imaging tool in the diagnosis of musculoskeletal system pathologies, it is quite sensitive to artifact-forming motion. Ultrasound (US) imaging is widely used in the evaluation of rotator cuff muscles, biceps muscle and glenohumeral joint pathologies and has many advantages over MRI, such as providing fast, cheap and dynamic imaging. Although many studies have proven that shoulder girdle musculoskeletal pathologies such as bicipital tendinitis, m.supraspinatus tendinosis, subacromial/subdeltoid bursitis, subacromial impingement syndrome, and adhesive capsulitis are seen more frequently in Parkinson's patients by ultrasonographic imaging, these shoulder girdle pathologies seen in Parkinson's patients are more common. The risk factors for pathologies have not been defined. In this study, we aimed to determine the ultrasonographic findings and risk factors of shoulder pathologies in Parkinson's patients and to investigate the effects of shoulder pathologies on quality of daily life, physical activity, falls and balance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease Shoulder Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

40 Parkinson's patients who described pain in at least one shoulder (VAS\>3)

ULTRASOUND

Intervention Type DIAGNOSTIC_TEST

Measurements will be made in musculoskeletal system ultrasonography by an international Medicine and Rehabilitation assistant physician using images obtained with the Sonosite M-Turbo device using the ImageJ program. During the measurements, the patient and the patient will be face to face and the device will be placed postero-laterally. Five standard window spacings will be used for the shoulder attachment. These are: anterior transverse, anterior longitudinal, lateral longitudinal, lateral transverse, posterior transverse.

Group 2

0 Parkinson's patients with undefined pain in both shoulders (VAS: 0)

ULTRASOUND

Intervention Type DIAGNOSTIC_TEST

Measurements will be made in musculoskeletal system ultrasonography by an international Medicine and Rehabilitation assistant physician using images obtained with the Sonosite M-Turbo device using the ImageJ program. During the measurements, the patient and the patient will be face to face and the device will be placed postero-laterally. Five standard window spacings will be used for the shoulder attachment. These are: anterior transverse, anterior longitudinal, lateral longitudinal, lateral transverse, posterior transverse.

Group 3

40 patients of similar age and gender, without a Parkinson's diagnosis, with any shoulder pain (VAS\>3)

ULTRASOUND

Intervention Type DIAGNOSTIC_TEST

Measurements will be made in musculoskeletal system ultrasonography by an international Medicine and Rehabilitation assistant physician using images obtained with the Sonosite M-Turbo device using the ImageJ program. During the measurements, the patient and the patient will be face to face and the device will be placed postero-laterally. Five standard window spacings will be used for the shoulder attachment. These are: anterior transverse, anterior longitudinal, lateral longitudinal, lateral transverse, posterior transverse.

Group 4

40 patients of similar age and gender, diagnosed without Parkinson's disease and without pain in both shoulders (VAS: 0)

ULTRASOUND

Intervention Type DIAGNOSTIC_TEST

Measurements will be made in musculoskeletal system ultrasonography by an international Medicine and Rehabilitation assistant physician using images obtained with the Sonosite M-Turbo device using the ImageJ program. During the measurements, the patient and the patient will be face to face and the device will be placed postero-laterally. Five standard window spacings will be used for the shoulder attachment. These are: anterior transverse, anterior longitudinal, lateral longitudinal, lateral transverse, posterior transverse.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ULTRASOUND

Measurements will be made in musculoskeletal system ultrasonography by an international Medicine and Rehabilitation assistant physician using images obtained with the Sonosite M-Turbo device using the ImageJ program. During the measurements, the patient and the patient will be face to face and the device will be placed postero-laterally. Five standard window spacings will be used for the shoulder attachment. These are: anterior transverse, anterior longitudinal, lateral longitudinal, lateral transverse, posterior transverse.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Group1

* Being diagnosed with Parkinson's according to the Movement Disorders Society diagnostic criteria
* Being over 50 years old
* Being in the Hoehn \& Yahr stage I-IV range
* Identification of pain in at least one shoulder (VAS\>3)
* Agreeing to participate in the study
* Being literate

Group2

* Being diagnosed with Parkinson's according to the Movement Disorders Society diagnostic criteria
* Being over 50 years old
* Being in the Hoehn \& Yahr stage I-IV range
* No pain in both shoulders (VAS: 0)
* Agreeing to participate in the study
* Being literate

Group 3

* Describe pain \>3 on the visual pain scale in any shoulder
* Being over 50 years old
* Becoming literate
* Agreeing to participate in the study

Group 4

1. Not defining pain with a score of 0 on the visual pain scale in both shoulders
2. Being over 50 years old
3. Being literate
4. Agreeing to participate in the study

Exclusion Criteria

* Scoring less than 24 points in the Mini Mental Test
* Having had a myocardial infarction
* Having had a cerebrovascular accident
* Having a rheumatological disease
* Known endocrine disease (Diabetes Mellitus, Hypo/hyperthyroidism)
* Cervical disc herniation defining radiculopathy
* Active trigger point palpated in the shoulder girdle muscles
* Having had any shoulder surgery
* Concomitant history of active systemic inflammatory disease, active infection and active malignancy
* Physical Therapy modalities have been applied in the last 6 months
* Having had an interventional procedure performed on the shoulder area within the last 6 months
* Using medications that may cause tendinopathy (Fluoroquinolines)
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MEHMET AKİF GÜLER, Ass. Prof.

Role: STUDY_DIRECTOR

SULTAN ABDÜLHAMIDHAN TRAINING AND RESEARCH HOSPITAL

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sultan 2. Abdulhamid Han Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

MÜRVET ARDA KÖROĞLU, MD

Role: CONTACT

00905353251323

EMRE ATA, Ass. Prof.

Role: CONTACT

00905336152162

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

emre ata, md

Role: primary

05336152162

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

24277

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.